Apeloa Pharmaceutical 普洛药业
22 significant filings since 29 May 2026: 8 on buyback, 5 on guarantee or financial assistance and 2 on dividend, and 4 other kinds. The latest, on 24 Sep 2026: 2026年中期分红派息实施公告. 1 unverified report logged, the latest on 22 Jun 2026.
自 29 May 2026 起有 22 份重大公告：buyback 8 份、guarantee or financial assistance 5 份、dividend 2 份，另有 4 类。最新一份（24 Sep 2026）：2026年中期分红派息实施公告。记录了 1 条未经核实的报道，最新一条见于 22 Jun 2026。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 2 brokers | 2 brokers |
| 7 days ago | 2 brokers | 2 brokers |
| 30 days ago | 2 brokers | 2 brokers |
| 60 days ago | 0.91 | 1.06 |
| 90 days ago | 0.91 | 1.07 |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus moved from 1.42 in Sep 2024 to 0.91 in Jul 2026 (-35.7%). 一致预期从 Sep 2024 的 1.42 变为 Jul 2026 的 0.91 (-35.7%)。 The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 0 = 0 | ▲ 0 ▼ 0 = 0 |
| Last 90 days | ▲ 0 ▼ 1 = 1 | ▲ 0 ▼ 0 = 2 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 1 and FY2024 had 0.